Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma

[1]  B. Zacharia,et al.  Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity , 2023, Journal of Cancer Research and Clinical Oncology.

[2]  E. Høgdall,et al.  Test of the FlashFREEZE unit in tissue samples freezing for biobanking purposes , 2022, Cell and Tissue Banking.

[3]  Kexin Chen,et al.  Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang , 2022, Biology of Sex Differences.

[4]  I. Baranowska-Bosiacka,et al.  Epidemiology of Glioblastoma Multiforme–Literature Review , 2022, Cancers.

[5]  J. Connor,et al.  Tumor cell-intrinsic HFE drives glioblastoma growth , 2022, bioRxiv.

[6]  Junwei Han,et al.  Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment , 2022, Molecular oncology.

[7]  N. Wages,et al.  Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma , 2021, Cells.

[8]  S. Sinha,et al.  Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets , 2021, Frontiers in Oncology.

[9]  M. Hahne,et al.  The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis , 2021, Cancers.

[10]  J. Oldenburg,et al.  Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis , 2021, International journal of molecular sciences.

[11]  A. Patrizi,et al.  Assessment of common housekeeping genes as reference for gene expression studies using RT-qPCR in mouse choroid plexus , 2021, Scientific Reports.

[12]  F. Costanzo,et al.  Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response , 2021, Cells.

[13]  A. Heimberger,et al.  MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme , 2020, Cancers.

[14]  John Quackenbush,et al.  Genome-Wide Sex and Gender Differences in Cancer , 2020, Frontiers in Oncology.

[15]  R. White,et al.  Deconstructing tumor heterogeneity: the stromal perspective , 2020, Oncotarget.

[16]  Shouwei Li,et al.  Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients , 2020, Cancer Cell International.

[17]  Qifu Li,et al.  miR-181a-5p inhibits the proliferation and invasion of drug-resistant glioblastoma cells by targeting F-box protein 11 expression , 2020, Oncology letters.

[18]  C. Bettegowda,et al.  "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing. , 2020, Neurosurgery.

[19]  L. Ginaldi,et al.  Sex and Gender Influences on Cancer Immunotherapy Response , 2020, Biomedicines.

[20]  D. Ribatti,et al.  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview , 2020, Translational oncology.

[21]  P. Leedman,et al.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology , 2020, Frontiers in Oncology.

[22]  C. Sautès-Fridman,et al.  The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression , 2020, Genome Medicine.

[23]  Z. Fan,et al.  Iron metabolism and its contribution to cancer (Review). , 2019, International journal of oncology.

[24]  N. Warrington,et al.  Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data , 2019, Science Translational Medicine.

[25]  Leland S. Hu,et al.  Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients , 2018, bioRxiv.

[26]  G. Pavesi,et al.  The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power. , 2018, World neurosurgery.

[27]  A. Tamimi,et al.  Epidemiology and Outcome of Glioblastoma , 2017 .

[28]  S. Hansen,et al.  Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value , 2017, PloS one.

[29]  G. Ning,et al.  Iron addiction: A novel therapeutic target in ovarian cancer , 2017, Oncogene.

[30]  P. Laurent-Puig,et al.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.

[31]  Baohui Liu,et al.  Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway , 2016, PloS one.

[32]  Nupur K. Das,et al.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.

[33]  S. Dudoit,et al.  Normalization of RNA-seq data using factor analysis of control genes or samples , 2014, Nature Biotechnology.

[34]  L. Kühn,et al.  Conditional Deletion of Ferritin H in Mice Reduces B and T Lymphocyte Populations , 2014, PloS one.

[35]  Lizhuang Yang,et al.  MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. , 2013, Molecular medicine reports.

[36]  I. Alafuzoff,et al.  Mast Cell Accumulation in Glioblastoma with a Potential Role for Stem Cell Factor and Chemokine CXCL12 , 2011, PloS one.

[37]  M. Santoro,et al.  Mast cells have a protumorigenic role in human thyroid cancer , 2010, Oncogene.

[38]  P. Stattin,et al.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. , 2010, The American journal of pathology.

[39]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[40]  S. Vandenberg,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008, BMC medicine.

[41]  K. Iwasaki,et al.  Intracellular iron transport and storage: from molecular mechanisms to health implications. , 2008, Antioxidants & redox signaling.

[42]  Kathryn A. O’Donnell,et al.  Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis , 2006, Molecular and Cellular Biology.

[43]  K. O'Byrne,et al.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Edward C Halperin,et al.  Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated? , 2003, Cancer.

[45]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[46]  C. Beaumont,et al.  H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload. , 2001, Blood.

[47]  E. Morgan,et al.  Ferritin and iron uptake by reticulocytes , 1983, British journal of haematology.

[48]  Domenico Ribatti,et al.  The controversial role of mast cells in tumor growth. , 2009, International review of cell and molecular biology.

[49]  Suzy V. Torti,et al.  Mouse brains deficient in H‐ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress , 2003, Journal of neuroscience research.